文献速递真菌感染

新型神经血浆置换疗法治疗隐球菌性脑膜炎

Novel Treatment of Cryptococcal Meningitis via Neurapheresis Therapy.
PubMed 文献 · J Infect Dis · 2018-01-01

隐球菌性脑膜炎是全球最常见的致死性真菌性脑膜炎,现有抗真菌序贯治疗未能实现稳定治愈。本文提出神经血浆置换疗法,通过体外过滤脑脊液清除酵母菌,体外24小时酵母菌浓度降低5个对数级、多糖抗原降低1个对数级,兔模型4-6小时清除97%酵母菌。

要点

  • 体外过滤脑脊液24小时酵母菌浓度降低5个对数级,多糖抗原降低1个对数级。
  • 兔模型闭环系统4-6小时清除蛛网膜下腔97%酵母菌。
  • 首次证明体外和体内均可快速清除隐球菌,为一次性治疗提供新思路。

核心结论

  • 神经血浆置换疗法是一种新型一次性治疗,首次证明体外和体内均可快速清除隐球菌,而该病原体自然清除缓慢并直接导致隐球菌性脑膜炎的发病和死亡。

研究设计与样本

  • 体外过滤脑脊液实验及兔模型闭环系统体内实验。

主要发现

  • 体外过滤脑脊液24小时酵母菌浓度降低5个对数级。
  • 体外过滤脑脊液24小时多糖抗原降低1个对数级。
  • 兔模型闭环系统4-6小时清除蛛网膜下腔97%的酵母菌。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cryptococcal meningitis (CM) has emerged as the most common life-threatening fungal meningitis worldwide. Current management involves a sequential, longitudinal regimen of antifungals; despite a significant improvement in survival compared with uniform mortality without treatment, this drug paradigm has not led to a consistent cure. Neurapheresis therapy, extracorporeal filtration of yeasts from cerebrospinal fluid (CSF) in infected hosts, is presented here as a novel, one-time therapy for CM. In vitro filtration of CSF through this platform yielded a 5-log reduction in concentration of the yeast and a 1-log reduction in its polysaccharide antigen over 24 hours. Additionally, an analogous closed-loop system achieved 97% clearance of yeasts from the subarachnoid space in a rabbit model over 4-6 hours. This is the first publication demonstrating the direct ability to rapidly clear, both in vitro and in vivo, the otherwise slowly removed fungal pathogen that directly contributes to the morbidity and mortality seen in CM.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Smilnak GJ, Charalambous LT, Cutshaw D, et al. Novel Treatment of Cryptococcal Meningitis via Neurapheresis Therapy. J Infect Dis. 2018. PMID: 29788431. doi:10.1093/infdis/jiy286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。